Related Experiment Video

Updated: Jun 25, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

Coronary artery disease in Brazil: contemporary management and future perspectives

C A Polanczyk1, J P Ribeiro

  • 1Cardiology Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. cpolanczyk@hcpa.ufrgs.br

Heart (British Cardiac Society)
|March 6, 2009
PubMed

Insights

Cardiovascular diseases cause 32% of deaths in Brazil, disproportionately affecting low-income populations. Addressing risk factors and improving healthcare access are crucial for prevention and treatment.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular diseases (CVDs) represent a significant cause of mortality in Brazil, accounting for 32% of all deaths.
  • Coronary artery disease (CAD) and cerebrovascular disease are the primary drivers of this mortality, with notable regional and socioeconomic disparities.
  • The burden of CAD is particularly high in Brazil's southern and southeastern regions and among low-income populations.

Purpose of the Study:

  • To analyze the epidemiological and socioeconomic factors influencing coronary artery disease in Brazil.
  • To evaluate the current healthcare structure's capacity to manage acute and chronic coronary artery disease.
  • To identify key areas for policy implementation and investment to improve cardiovascular care nationwide.

Main Methods:

  • Review of epidemiological data on cardiovascular disease mortality in Brazil.
  • Analysis of socioeconomic determinants impacting CAD distribution and severity.
  • Assessment of the Brazilian healthcare system's public and private components in relation to cardiac care.

Main Results:

  • Significant regional inequalities exist in medical care access and outcomes for coronary artery disease.
  • Low-income populations experience higher mortality rates from cardiovascular diseases.
  • While some institutions offer advanced care, systemic gaps in primary prevention, tertiary care, and continuity of care persist.

Conclusions:

  • National policies are essential to combat cardiovascular disease risk factors and enhance primary prevention strategies.
  • Substantial investments are required to improve tertiary care, reorganize acute patient management systems, and ensure equitable access to cardiac care and secondary prevention.
  • Collaboration between public and private health sectors is vital for implementing effective national strategies against cardiovascular diseases.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...